Heart Disease News and Research

Latest Heart Disease News and Research

Disabled and elderly people can benefit from new hand-held computer

Disabled and elderly people could find it easier to navigate around town and city centres with a new hand-held computer being developed by a geographical information systems professor at Kingston University in South West London.

27 Jan 2011

NHS reforms & proposed spending questioned

According to John Appleby, Chief Economist at the King’s Fund, deaths from heart attacks and cancer in the UK are falling despite lower spending on health than in countries such as France. This, he said calls attention to the Government’s claim that poor outcomes justify a £1.4 billion restructuring of the NHS that will pass control of budgets from managers to GPs. He said, “Comparing health outcomes across countries is complex and not simply down to healthcare spending, but these trends must challenge one of the government’s key justifications for reforming the NHS.”

27 Jan 2011

Interferon-alpha associated with increased risk of atherosclerosis in patients with SLE

Researchers in China have demonstrated interferon-alpha (IFN-α) is associated with increased risk of atherosclerosis in patients with systemic lupus erythematosus (SLE). For the first time, IFN-α priming was shown to promote lipid uptake and foam cell formation—a crucial step in plaque build-up. This activation of the IFN signaling pathway may be linked to the premature atherosclerosis risk in SLE.

27 Jan 2011

St. Michael's Hospital to build first automated high-throughput zebrafish screening facility in Canada

Zebrafish are the new fruit flies.

27 Jan 2011

AVRF and UPEI collaboration awarded Innovation PEI Pilot and Discovery Fund grant

Atlanta Vascular Research Foundation (AVRF), together with its collaborators at the University of Prince Edward Island (UPEI), has been awarded an Innovation PEI Pilot and Discovery Fund grant by Innovation PEI. The grant is to continue research and development in combining nutraceuticals to magnify clinical benefits for the prevention and treatment of cardiovascular and metabolic diseases. The funding from this grant is $25,000.

27 Jan 2011

Phase III study affirms safety and efficacy of Cumberland's Caldolor for post-operative pain

Cumberland Pharmaceuticals Inc. today announced the publication of data affirming the safety and efficacy of Caldolor® (ibuprofen) Injection in treating post-operative pain in hospitalized patients. A Phase III study published in the peer-reviewed journal Pain Practice concluded that IV ibuprofen significantly reduced both morphine use and self-reported pain intensity in patients recovering from abdominal hysterectomy compared to morphine alone.

27 Jan 2011

NQF endorses outcome measures to improve quality of care for people with mental illnesses

The National Quality Forum has endorsed outcome measures to assess the results and thereby improve the quality of care provided to people with mental illnesses. The 4 endorsed mental health measures focus on depression and patients' satisfaction during an inpatient psychiatric hospital stay.

27 Jan 2011

IDEV announces release of SUPERA stent data from Leipzig Registry

IDEV Technologies, Incorporated, an innovative leader in the development and commercialization of minimally invasive medical technologies, today announced the release of two-year European data from the prominent Leipzig Registry, which tracks patients treated with the SUPERA wire interwoven nitinol stent.

27 Jan 2011

Merck Canada invests in CQDM to support biopharmaceutical research

Merck Canada has renewed its partnership with the Quebec Consortium for Drug Discovery by investing a further $5 million over five years in the organization so it can continue its support of biopharmaceutical research in Quebec.

27 Jan 2011

FDA approves Corindus CorPath 200 System for pivotal trial to evaluate safety, effectiveness

Corindus Vascular Robotics, a leading developer of precision vascular robotics, today announced it has been granted Food and Drug Administration conditional Investigational Device Exemption approval to evaluate the safety and effectiveness of its CorPath® 200 System in delivering and manipulating coronary guidewires and stent/balloon systems in percutaneous coronary interventions procedures.

27 Jan 2011

Metanx promotes restoration of lost cutaneous sensation in Diabetic Neuropathy patients

PamLab L.L.C., developer and marketer of Metanx®, announced today that the results of a study to determine if nutritional management with Metanx® improves numbness in the feet of patients with Diabetic Neuropathy (DN) was published in the fourth quarter 2010 issue of Reviews in Neurological Diseases. The study demonstrated that Metanx®, a medical food available by prescription, promotes restoration of lost cutaneous sensation in DN patients.

27 Jan 2011

How estrogen decreases risk and delays onset and progression of Alzheimer's disease

An influential article in the journal Progress in Neurobiology provided one of the first comprehensive reviews of how estrogen potentially can protect against Alzheimer's disease and other neurological disorders.

27 Jan 2011

NIH study helps explain survival rate discrepancy between cardiac arrest in public and home

Cardiac arrests that can be treated by electric stimulation, also known as shockable arrests, were found at a higher frequency in public settings than in the home, according to a National Institutes of Health-funded study appearing in the Jan. 27 issue of the New England Journal of Medicine.

27 Jan 2011

Mount Sinai's Cardiac Catheterization Lab wins New York State's highest 'two-star' safety rating

Mount Sinai's Cardiac Catheterization Laboratory has been awarded New York State's highest "two-star" safety rating in every category of case the state tracks for percutaneous coronary intervention, according to new data released this month that examine patient discharges from 2006 - 2008.

27 Jan 2011

Researchers discover new sensory neurons that mediate BP and metabolism regulation in liver

For 60 years, scientists have puzzled over the possibility of a hepatic osmoreceptor that influences blood pressure regulation. Now, researchers of the Max Delbr-ck Center for Molecular Medicine Berlin-Buch, the Experimental and Clinical Research Center of the MDC and Charit- and the Hannover Medical School appear to have made a breakthrough discovery.

27 Jan 2011

FDA Advisory Committee recommends expanded indication for Abbott's RX ACCULINK Carotid Stent System

Abbott today announced that the U.S. Food and Drug Administration (FDA) Circulatory System Devices Panel of the Medical Devices Advisory Committee voted that, for symptomatic and asymptomatic carotid artery disease patients at standard surgical risk, there is reasonable assurance that the benefits of the RX ACCULINK® Carotid Stent System outweigh its risks (Yes: 7, No: 3, Abstain: 1).

27 Jan 2011

Tryton initiates enrollment in Side Branch Stent System study

Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced that the first U.S. patient has been enrolled in the pivotal trial to evaluate the Tryton Side Branch Stent System™ for the treatment of coronary artery disease.

27 Jan 2011

Boston Scientific initiates enrollment in comparative Chinese study of PROMUS Element Everolimus-Eluting Stent

Boston Scientific Corporation today announced the beginning of patient enrollment in the PLATINUM China clinical trial, which is designed to evaluate the safety and effectiveness of the Company's PROMUS Element™ Everolimus-Eluting Platinum Chromium Coronary Stent compared to the TAXUS® Liberte® Paclitaxel-Eluting Coronary Stent in the treatment of patients with a single de novo atherosclerotic lesion.

27 Jan 2011

War-time stress may lead to increased risk of death by coronary heart disease in later life

War-time stress may lead to an increased risk death by coronary heart disease in later life. Researchers writing in BioMed Central's open access journal BMC Health Services Research surveyed a cohort of 55 year old Finnish WW2 veterans in 1980, and then carried out a follow-up study 28 years later.

27 Jan 2011

Researchers find food-borne bacteria can cause difficult-to-treat heart infections

Researchers at the University of Illinois at Chicago College of Medicine have found that particular strains of a food-borne bacteria are able to invade the heart, leading to serious and difficult-to-treat heart infections.

27 Jan 2011

Heart Disease News and Research

Latest Heart Disease News and Research

Disabled and elderly people can benefit from new hand-held computer

NHS reforms & proposed spending questioned

Interferon-alpha associated with increased risk of atherosclerosis in patients with SLE

St. Michael's Hospital to build first automated high-throughput zebrafish screening facility in Canada

AVRF and UPEI collaboration awarded Innovation PEI Pilot and Discovery Fund grant

Phase III study affirms safety and efficacy of Cumberland's Caldolor for post-operative pain

NQF endorses outcome measures to improve quality of care for people with mental illnesses

IDEV announces release of SUPERA stent data from Leipzig Registry

Merck Canada invests in CQDM to support biopharmaceutical research

FDA approves Corindus CorPath 200 System for pivotal trial to evaluate safety, effectiveness

Metanx promotes restoration of lost cutaneous sensation in Diabetic Neuropathy patients

How estrogen decreases risk and delays onset and progression of Alzheimer's disease

NIH study helps explain survival rate discrepancy between cardiac arrest in public and home

Mount Sinai's Cardiac Catheterization Lab wins New York State's highest 'two-star' safety rating

Researchers discover new sensory neurons that mediate BP and metabolism regulation in liver

FDA Advisory Committee recommends expanded indication for Abbott's RX ACCULINK Carotid Stent System

Tryton initiates enrollment in Side Branch Stent System study

Boston Scientific initiates enrollment in comparative Chinese study of PROMUS Element Everolimus-Eluting Stent

War-time stress may lead to increased risk of death by coronary heart disease in later life

Researchers find food-borne bacteria can cause difficult-to-treat heart infections

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Heart Disease News and Research

Latest Heart Disease News and Research

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Newsletters you may be interested in